Global Information
회사소개 | 문의

대장암 : 파이프라인 리뷰

Colorectal Cancer - Pipeline Review, H1 2018

리서치사 Global Markets Direct
발행일 2018년 06월 상품 코드 232768
페이지 정보 영문 2237 Pages
가격
US $ 2,500 ₩ 2,822,000 PDF by E-mail (Single user license) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,000 ₩ 5,644,000 PDF by E-mail (Site license) help
동일 사업장 내 모든 분들이 공유하여 사용할 수 있습니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 2부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 7,500 ₩ 8,466,000 PDF by E-mail (Global license) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없으며, 해외 사업장 및 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 10부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


대장암 : 파이프라인 리뷰 Colorectal Cancer - Pipeline Review, H1 2018
발행일 : 2018년 06월 페이지 정보 : 영문 2237 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

한글목차

대장암은 결장 또는 직장에서 발생하기 시작하는 암으로, 그 증상으로는 설사나 변비, 혈변, 격렬한 복통, 만복감이나 팽만감, 원인 불명의 체중 감소, 권태감, 오심, 구토 등이 있습니다. 대장암 발병 원인으로는 흡연, 2형 당뇨병, 대장암 가족력 등이 있습니다.

대장암(Colorectal Cancer) 치료제의 파이프라인 제품 개요, 임상시험 단계별 제품 개요, 주요 기업 개요, 약제 개요, 파이프라인 제품의 최신 동향 등을 전해드립니다.

서론

  • 조사 범위

대장암 개요

치료제 개발

  • 파이프라인 제품 개요
  • 파이프라인 제품 비교 분석

대장암 : 기업에서 개발중인 치료제

대장암 : 대학/기관에서 연구중인 치료제

대장암 : 파이프라인 제품 개요

  • 후기 단계 제품
  • 임상 단계 제품
  • 초기 단계 제품
  • 개발 단계가 불명확한 제품

대장암 : 기업에서 개발중인 제품

대장암 : 대학/기관에서 연구중인 제품

대장암 치료제 개발에 참여하고 있는 기업

대장암 : 치료제 평가

  • 단독치료 제품(Monotherapy Products)별
  • 병용 제품(Combination Products)별
  • 표적별
  • 작용기전별
  • 투여 경로별
  • 분자 종류별

약제 개요

대장암 : 휴지 상태인 프로젝트

대장암 : 개발이 중지된 제품

대장암 : 제품 개발 마일스톤

  • 주요 뉴스와 프레스 릴리스

부록

LSH 16.09.30

List of Tables

  • Number of Products under Development for Colorectal Cancer, H1 2018
  • Number of Products under Development by Companies, H1 2018
  • Number of Products under Development by Universities/Institutes, H1 2018
  • Products under Development by Companies, H1 2018
  • Products under Development by Universities/Institutes, H1 2018
  • Number of Products by Stage and Target, H1 2018
  • Number of Products by Stage and Mechanism of Action, H1 2018
  • Number of Products by Stage and Route of Administration, H1 2018
  • Number of Products by Stage and Molecule Type, H1 2018
  • Colorectal Cancer - Pipeline by 3-V Biosciences Inc, H1 2018
  • Colorectal Cancer - Pipeline by 3SBio Inc, H1 2018
  • Colorectal Cancer - Pipeline by 4SC AG, H1 2018
  • Colorectal Cancer - Pipeline by AB Science SA, H1 2018
  • Colorectal Cancer - Pipeline by AbbVie Inc, H1 2018
  • Colorectal Cancer - Pipeline by AbGenomics International Inc, H1 2018
  • Colorectal Cancer - Pipeline by Abpro, H1 2018
  • Colorectal Cancer - Pipeline by Aclaris Therapeutics Inc, H1 2018
  • Colorectal Cancer - Pipeline by Adamed Sp z oo, H1 2018
  • Colorectal Cancer - Pipeline by Aduro BioTech Inc, H1 2018
  • Colorectal Cancer - Pipeline by Advenchen Laboratories LLC, H1 2018
  • Colorectal Cancer - Pipeline by AlfaSigma SpA, H1 2018
  • Colorectal Cancer - Pipeline by Alligator Bioscience AB, H1 2018
  • Colorectal Cancer - Pipeline by Allinky Biopharma, H1 2018
  • Colorectal Cancer - Pipeline by Amarin Corp Plc, H1 2018
  • Colorectal Cancer - Pipeline by amcure GmbH, H1 2018
  • Colorectal Cancer - Pipeline by Amgen Inc, H1 2018
  • Colorectal Cancer - Pipeline by Antibe Therapeutics Inc, H1 2018
  • Colorectal Cancer - Pipeline by APEIRON Biologics AG, H1 2018
  • Colorectal Cancer - Pipeline by Apexigen Inc, H1 2018
  • Colorectal Cancer - Pipeline by Aphios Corp, H1 2018
  • Colorectal Cancer - Pipeline by Aposense Ltd, H1 2018
  • Colorectal Cancer - Pipeline by Arcus Biosciences Inc, H1 2018
  • Colorectal Cancer - Pipeline by ARMO Biosciences Inc, H1 2018
  • Colorectal Cancer - Pipeline by ArQule Inc, H1 2018
  • Colorectal Cancer - Pipeline by Array BioPharma Inc, H1 2018
  • Colorectal Cancer - Pipeline by Asana BioSciences LLC, H1 2018
  • Colorectal Cancer - Pipeline by Ascelia Pharma AB, H1 2018
  • Colorectal Cancer - Pipeline by Aslan Pharmaceuticals Pte Ltd, H1 2018
  • Colorectal Cancer - Pipeline by Astellas Pharma Inc, H1 2018
  • Colorectal Cancer - Pipeline by Astex Pharmaceuticals Inc, H1 2018
  • Colorectal Cancer - Pipeline by AstraZeneca Plc, H1 2018
  • Colorectal Cancer - Pipeline by Aurigene Discovery Technologies Ltd, H1 2018
  • Colorectal Cancer - Pipeline by Aurobindo Pharma Ltd, H1 2018
  • Colorectal Cancer - Pipeline by AVEO Pharmaceuticals Inc, H1 2018
  • Colorectal Cancer - Pipeline by B Cell Design SAS, H1 2018
  • Colorectal Cancer - Pipeline by Basilea Pharmaceutica Ltd, H1 2018
  • Colorectal Cancer - Pipeline by Bavarian Nordic A/S, H1 2018
  • Colorectal Cancer - Pipeline by Bayer AG, H1 2018
  • Colorectal Cancer - Pipeline by BeiGene Ltd, H1 2018
  • Colorectal Cancer - Pipeline by Beijing Hanmi Pharmaceutical Co Ltd, H1 2018
  • Colorectal Cancer - Pipeline by BeyondSpring Pharmaceuticals Inc, H1 2018
  • Colorectal Cancer - Pipeline by Biocon Ltd, H1 2018
  • Colorectal Cancer - Pipeline by Bionomics Ltd, H1 2018
  • Colorectal Cancer - Pipeline by Bionovis SA, H1 2018
  • Colorectal Cancer - Pipeline by Biotecnol Ltd, H1 2018
  • Colorectal Cancer - Pipeline by Biothera Pharmaceutical Inc, H1 2018
  • Colorectal Cancer - Pipeline by Boehringer Ingelheim GmbH, H1 2018
  • Colorectal Cancer - Pipeline by Boston Biomedical Inc, H1 2018
  • Colorectal Cancer - Pipeline by Bristol-Myers Squibb Co, H1 2018
  • Colorectal Cancer - Pipeline by Calithera Biosciences Inc, H1 2018
  • Colorectal Cancer - Pipeline by Cancer Prevention Pharmaceuticals Inc, H1 2018
  • Colorectal Cancer - Pipeline by Cancer Research Technology Ltd, H1 2018
  • Colorectal Cancer - Pipeline by Cantargia AB, H1 2018
  • Colorectal Cancer - Pipeline by Carna Biosciences Inc, H1 2018

List of Figures

  • Number of Products under Development for Colorectal Cancer, H1 2018
  • Number of Products under Development by Companies, H1 2018
  • Number of Products under Development by Universities/Institutes, H1 2018
  • Number of Products by Top 10 Targets, H1 2018
  • Number of Products by Stage and Top 10 Targets, H1 2018
  • Number of Products by Top 10 Mechanism of Actions, H1 2018
  • Number of Products by Stage and Top 10 Mechanism of Actions, H1 2018
  • Number of Products by Top 10 Routes of Administration, H1 2018
  • Number of Products by Stage and Top 10 Routes of Administration, H1 2018
  • Number of Products by Top 10 Molecule Types, H1 2018
  • Number of Products by Stage and Top 10 Molecule Types, H1 2018

영문목차

Summary:

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colorectal Cancer - Pipeline Review, H1 2018, provides an overview of the Colorectal Cancer (Oncology) pipeline landscape.

Colorectal cancer is a cancer that starts in the colon or the rectum. Colorectal cancers begin as a growth called a polyp on the inner lining of the colon or rectum. Symptoms include abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation, change in bowel habits, narrow stools and weight loss with no known reason. Risk factors include smoking, heavy alcohol use, inflammatory bowel disease (IBD) and family history. Treatment includes surgery, radiation therapy and chemotherapy.

Report Highlights:

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Colorectal Cancer - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Colorectal Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Colorectal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Colorectal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 5, 1, 27, 132, 157, 16, 185, 32 and 14 respectively. Similarly, the Universities portfolio in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages comprises 1, 23, 9, 1, 30 and 3 molecules, respectively.

Colorectal Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Colorectal Cancer (Oncology).
  • The pipeline guide reviews pipeline therapeutics for Colorectal Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Colorectal Cancer (Oncology) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Colorectal Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Colorectal Cancer (Oncology)

Reasons to buy:

  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Colorectal Cancer (Oncology).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Colorectal Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

  • Table of Contents
  • Introduction
  • Colorectal Cancer - Overview
  • Colorectal Cancer - Therapeutics Development
  • Colorectal Cancer - Therapeutics Assessment
  • Colorectal Cancer - Companies Involved in Therapeutics Development
  • Colorectal Cancer - Drug Profiles
  • Colorectal Cancer - Dormant Projects
  • Colorectal Cancer - Discontinued Products
  • Colorectal Cancer - Product Development Milestones
  • Appendix
Back to Top
아시아 최대 시장정보 제공
전세계에서 발행되고 있는 모든 시장조사보고서를
다루고 있습니다.
사이트에서 검색되지 않는 보고서도 문의 바랍니다.
 
BCC Research